Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Werewolf Therapeutics
Biotech
Werewolf weighs sale or merger as cash reserves whimper
The immuno-oncology outfit is weighing a full range of strategic options, including a merger or selling the company or its assets.
Darren Incorvaia
Feb 24, 2026 5:23pm
AIRNA appoints Elevidys architect as CMO—Chutes & Ladders
Apr 18, 2025 8:30am
BioMarin hires ex-Roche leader Hubbard as CCO—Chutes & Ladders
Mar 8, 2024 9:30am
Jazz, Werewolf to howl at the moon in $1.26M biobucks deal
Apr 7, 2022 9:35am
Synthekine snags $108M to drive two candidates into the clinic
Jun 10, 2021 8:00am
Werewolf Therapeutics howls onto the Nasdaq with $120M IPO
Apr 30, 2021 10:16am
